Estracyt
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryThe pharmacokinetics of estramustine phosphate (EMP) was studied in five prostatic cancer patients given single i.v. and…
The [3H]estramustine-binding macromolecule in human prostate was partially characterized using a number of chromatographic…
Plasma concentrations of estramustine phosphate and its major metabolites were measured in patients with prostatic carcinoma…
Two types of experiments were performed to elucidate the estrogenic effect of estracyt on the ventral and immature rats that had…
Estraumustine phosphate (estradiol, 3-N-[bis(2-chloroethyl)-] carbamate-17beta-dihydrogenphosphate (Estracyt) labeled with 3H in…
Estracyt, a compound of nitrogen-mustard linked to oestradiol phosphate, is used in the treatment of human prostatic cancer. The…
SUMMARY Estracyt, a chemical ester of a nitrogen mustard with estradiol-17/3, was tested for its antiprostatic effects in dogs…
The activity and distribution of five hydrolytic enzymes in human prostatic carcinomatous tissue were studied before and during…
A 75-year-old man with metastasising prostatic carcinoma was treated with Estracyt® (estradiol-3-N[bis-(2-chlorethyl)]-carbamate…